Product Details

Zolmitriptan ODT

Zolmitriptan
2.5 mg
Orally Disintegrating Tablet


DIN/PIN/NPN

02442671

Manufacturer

Sanis Health Inc.

Formulary Listing Date

2020-08-28  

Unit Price

6.8633

Amount MOH Pays

6.8633

Coverage Status

Off-Formulary Interchangeable Exceptional Access Program Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

N02CC03

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02243045 Zomig Rapimelt 16.9773 6.8633
02442671 Zolmitriptan ODT 6.8633 6.8633
02342545 Teva-Zolmitriptan OD 6.8633 6.8633
02428474 Septa-Zolmitriptan-ODT 6.8633 6.8633
02362996 Sandoz Zolmitriptan ODT 6.8625 6.8625
02324768 PMS-Zolmitriptan ODT 6.8625 6.8625
02419513 Mint-Zolmitriptan ODT 6.8625 6.8625
02428237 Jamp-Zolmitriptan ODT 6.8633 6.8633
02381575 Apo-Zolmitriptan Rapid 6.8633 6.8633
 

LU Clinical Criteria

NO  

EAP Criteria

Therapeutic Class Reimbursement Criteria
Migraine Drugs

Zolmitriptan

  • Brand(s): Zomig
  • Dosage Form/Strength: 2.5 mg tablet

  • Brand(s): Zomig Rapimelt
  • Dosage Form/Strength: 2.5 mg dispersible tablet

For the treatment of migraines with or without aura in patients who have failed an adequate trial of or experienced intolerance to all other oral triptans considered under the Exceptional Access Program. 

Duration of Approvals: 5 years 

Renewal requests may be considered for patients who continue to benefit from treatment. The physician must provide the frequency of triptan use.

EAP Drug Request Form:

Standard Form for EAP Drug Requests

Product Monograph

View Monograph